Cargando…
Encapsulated Papillary Thyroid Tumor with Delicate Nuclear Changes and a KRAS Mutation as a Possible Novel Subtype of Borderline Tumor
Although papillary thyroid carcinoma (PTC)–type nuclear changes are the most reliable morphological feature in the diagnosis of PTC, the nuclear assessment used to identify these changes is highly subjective. Here, we report a noninvasive encapsulated thyroid tumor with a papillary growth pattern me...
Autores principales: | Ohba, Kenji, Mitsutake, Norisato, Matsuse, Michiko, Rogounovitch, Tatiana, Nishino, Nobuhiko, Oki, Yutaka, Goto, Yoshie, Kakudo, Kennichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435983/ https://www.ncbi.nlm.nih.gov/pubmed/30636389 http://dx.doi.org/10.4132/jptm.2018.12.07 |
Ejemplares similares
-
MON-628 Noninvasive Encapsulated Papillary RAS-Like Thyroid Tumor (NEPRAS) as a Possible Novel Subtype of Borderline Tumor
por: Ohba, Kenji, et al.
Publicado: (2019) -
SUN-LB78 Hyperfunctioning Papillary Thyroid Carcinoma With a BRAF Mutation
por: Shinkai, Shinsuke, et al.
Publicado: (2020) -
New insights into classification and risk stratification of encapsulated thyroid tumors with a predominantly papillary architecture
por: Jung, Chan Kwon, et al.
Publicado: (2020) -
BRAF(V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from Chernobyl
por: Mitsutake, Norisato, et al.
Publicado: (2015) -
TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors
por: Matsuse, Michiko, et al.
Publicado: (2017)